January 2020 — When Fasha Mahjoor launched Neoteryx, he planned to change the way dried capillary blood is collected, to become the most significant blood microsampling innovator in the modern marketplace. In that, he and his team have surely succeeded.
In just a few years, Neoteryx has improved small-volume blood collection for those across the spectrum of science, research, and healthcare. Relevant areas include:
This is all happening on the strength of two absurdly simple, enormously impactful innovations.
Volumetric Absorptive Microsampling (VAMS®), a smarter, simpler, more economical, and more convenient quantitive method for the small-volume collection of blood and other biological fluids
Mitra® devices, available in patient- and lab-facing configurations from Neoteryx
2020 is poised to be another year of enormous growth for Neoteryx, VAMS, and Mitra. We are opening new care pathways, improving age-old processes of drug development and monitoring, and working with the sharpest minds in science, research, and healthcare. And we want you to be a part of it.
If you've put off investigating dried blood microsampling solutions and systems for yourself, now is the time.